Virtue Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Virtue Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,669	Closed	-$623K	–	326
2025 Q1	$623K	Buy	+3,669	New	+$637K	0.07%	222
2024 Q3	–	Sell	-1,892	Closed	-$307K	–	303
2024 Q2	$307K	Sell	1,892 -23	-1%	-$3.45K	0.05%	286
2024 Q1	$286K	Hold	1,915	–	–	0.05%	302
2023 Q4	$302K	Sell	1,915 -67	-3%	-$9.63K	0.06%	284
2023 Q3	$303K	Hold	1,982	–	–	0.05%	308
2023 Q2	$303K	Hold	1,982	–	–	0.05%	306
2023 Q1	$300K	Sell	1,982 -42	-2%	-$6.6K	0.05%	308
2022 Q4	$312K	Hold	2,024	–	–	0.05%	281
2022 Q3	$267K	Sell	2,024 -325	-14%	-$45.6K	0.04%	196
2022 Q2	$318K	Sell	2,349 -1,221	-34%	-$168K	0.05%	178
2022 Q1	$532K	Sell	3,570 -44	-1%	-$6.51K	0.08%	256
2021 Q4	$585K	Buy	+3,614	New	+$584K	0.09%	251
2019 Q3	–	Sell	-8,118	Closed	-$1.14M	–	233
2019 Q2	$1.14M	Sell	8,118 -1,530	-16%	-$211K	0.42%	78
2019 Q1	$1.46M	Buy	+9,648	New	+$1.39M	0.51%	16
2018 Q4	–	Sell	-25,878	Closed	-$4.1M	–	135
2018 Q3	$4.1M	Buy	+25,878	New	+$3.92M	0.87%	32

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtue Capital Management's FBT Position: Q2 2025 in Review

Virtue Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2025, closing a stake of 3,669 shares — an estimated $623K sold.

Virtue Capital Management first reported a position in FBT in Q3 2018 and held it in 15 quarters. The position peaked at $4.1M in Q3 2018. 250 funds tracked by Wall St. Rank hold FBT as of Q2 2025.

Virtue Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2025 after selling out during the quarter.
Virtue Capital Management sold 3,669 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2025, an estimated $623K.
Virtue Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 15 quarters.
Virtue Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.1M in Q3 2018.
250 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2025.

Based on Virtue Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.